Alzamend Neuro Initiates Phase Ii Clinical Trial Of Al001 "Lithium In Brain" Study In Patients With Bipolar Disorder In Collaboration With Massachusetts General Hospital
ALZAMEND NEURO INITIATES PHASE II CLINICAL TRIAL OF AL001 "LITHIUM IN BRAIN" STUDY IN PATIENTS WITH BIPOLAR DISORDER IN COLLABORATION WITH MASSACHUSETTS GENERAL HOSPITAL
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.